Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial

BACKGROUND: Inhaled glucocorticosteroids (ICS) are the mainstay of treatment in asthma. Fluticasone furoate (FF) is a novel, once-daily ICS asthma therapy. This study investigated the efficacy and safety of FF 50 mcg in patients with mild-to-moderate persistent asthma. METHODS: A 24-week, multicente...

Descripción completa

Detalles Bibliográficos
Autores principales: Busse, W W, Bateman, E D, O'Byrne, P M, Lötvall, J, Woodcock, A, Medley, H, Forth, R, Jacques, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329337/
https://www.ncbi.nlm.nih.gov/pubmed/25040613
http://dx.doi.org/10.1111/all.12480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329337/
https://www.ncbi.nlm.nih.gov/pubmed/25040613
http://dx.doi.org/10.1111/all.12480

Ejemplares similares